Clinical trials
Recruiting Phase 1 Melanoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 8 |
| 2022 | 8 |
| 2023 | 6 |
| 2024 | 10 |
| 2025 | 19 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 65 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 5 |
| Biocon Biologics UK PLC | 2 |
| Duke University | 2 |
| Hefei TG ImmunoPharma Co., Ltd. | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Adze Biotechnology Australia Pty Ltd | 1 |
| Alvotech Swiss AG | 1 |
| Anusha Kalbasi | 1 |
| BioEclipse Therapeutics | 1 |
| Boehringer Ingelheim | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 65 |
| Carcinoma, Non-Small-Cell Lung | 18 |
| Neoplasm Metastasis | 11 |
| Colorectal Neoplasms | 10 |
| Neoplasms | 10 |
| Squamous Cell Carcinoma of Head and Neck | 10 |
| Breast Neoplasms | 8 |
| Carcinoma, Hepatocellular | 8 |
| Triple Negative Breast Neoplasms | 8 |
| Lung Neoplasms | 7 |
Trials
Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.